India, Feb. 18 -- The product portfolio for Nectar ranges from essential anti-diabetic formulations to combination medications, offering comprehensive solutions for Type 2 diabetes management

Nectar Life Care has announced the launch of a new range of high-quality, cost-effective anti-diabetic formulations, withDapagliflozin under the brand name DAPNEC. With the expiration of API patents, these medicines will now be available at affordable prices, enhancing accessibility while maintaining high efficacy.

India, often called the 'Diabetes Capital of the World,' faces a rising demand for effective diabetes management solutions. Type 2 diabetes, once prevalent among adults, is now increasingly affecting younger individuals due to sedentary ...